At a glance
ClinicalIndex Comparison RecordN/ACompleted· 125 enrolled
Drug / intervention
Blood sampleother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Molecular Diagnosis of Primary Ciliary Dyskinesia
In Brief
An observational study evaluating Blood sample for Primary Ciliary Dyskinesia and Kartagener Syndrome. Completed, enrolled 125 participants across 1 site.
Detailed Summary
Primary ciliary dyskinesia is an inherited respiratory disease caused by various functional and ultrastructural abnormalities of respiratory cilia. The genetic heterogeneity underlying PCD is extremely important and only few genes are clearly implicated in PCD. Their mutations account for about 20% of patients. For all the other PCD patients, the genes responsible for their ciliary defect remain to be identify.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPrimary Ciliary Dyskinesia, Kartagener Syndrome
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 2008
Enrollment StartJan 2010
Primary CompletionDec 2012
TodayJul 2026
First PostedNov 3, 2008
Enrollment StartJan 1, 2010
Primary CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 17.7 years ago
Interventions
Blood sampleother
Blood sample of 5 ml